Welcome to #1 DIGITAL HEALTH NEWS Portal

Highland Marketing Welcomes New Member to its Advisory Board

Highland Marketing has welcomed a new member to its advisory board of respected NHS IT leaders and health tech industry professionals.

Nicola Haywood-Alexander, a chief information officer and digital transformation adviser, who has worked in both the NHS and the wider public sector, has joined the expert group that provides advice to the health tech agency and its clients.

Read more ...

Philips Launches Next Generation Wearable Biosensor for Early Patient Deterioration Detection, Including Clinical Surveillance for COVID-19

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its wearable biosensor (Philips Biosensor BX100) to help manage confirmed and suspected COVID-19 patients in the hospital.

Read more ...

Mental Health Prescribing Goes Digital at Humber, Enhancing Patient Safety

Humber Teaching NHS Foundation Trust, with services focused on citizens across a large area of Yorkshire, has gone live with DXC Lorenzo Electronic Prescribing and Medication Management (ePMA), a new digital approach to prescribing and administering medicines for NHS mental health professionals.

Read more ...

First Virtual DMEA to Open with a Wide Range of Topics

16 - 18 June 2020, Berlin, Germany.
Under the heading 'DMEA sparks' and taking place for the first time, this year's DMEA is an entirely virtual event. From 16 to 18 June 2020 a wide-ranging programme of events including panels, keynote speeches and webinars can be accessed on the new platform.

Read more ...

Researchers Identify Healthcare Data Defects

Researchers at the University of Maryland, Baltimore County (UMBC) have developed a method to investigate the quality of healthcare data using a systematic approach, which is based on creating a taxonomy for data defects thorough literature review and examination of data. Using that taxonomy, the researchers developed software that automatically detects data defects effectively and efficiently.

Read more ...

Siemens Healthineers Now Shipping Worldwide Total Antibody Test and Molecular Test Kit for COVID-19 with Expanded Capacity

Siemens Healthineers announced that it is now shipping worldwide its laboratory-based total antibody test(1) to detect the presence of SARS-CoV-2 IgM and IgG antibodies in blood. The test received the CE mark and data has demonstrated 100 percent sensitivity(2) and 99.8 percent specificity.

Read more ...

Digital Contact Tracing for COVID-19: An Analysis of Strengths and Limitations

An article in CMAJ (Canadian Medical Association Journal) analyzes the strengths and limitations of digital contact tracing for people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to help governments decide if and how they might adopt this technology.

Read more ...

Philips Launches Next Generation Wearable Biosensor for Early Patient Deterioration Detection, Including Clinical Surveillance for COVID-19

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its wearable biosensor (Philips Biosensor BX100) to help manage confirmed and suspected COVID-19 patients in the hospital.

Read more ...

Telehealth Tools Developed for Ebola Improve COVID-19 Care

Telemedicine tools developed at UVA Health to battle Ebola have huge potential in the fight against COVID-19, UVA experts report in a new scientific paper. The tools, they say, allow doctors to provide personal, high-quality care while conserving vital personal protective equipment and reducing infection risks.

Read more ...

Statistical Approach to COVID-19 Clinical Trials Aims to Accelerate Drug Approval Process

In response to the COVID-19 pandemic, researchers from the Massachusetts Institute of Technology have published a pair of studies in a COVID-19 special issue of the Harvard Data Science Review, freely available via open access, describing new methods for accelerating drug approvals during pandemics and for providing more accurate measures of the probabilities of success for clinical trials of vaccines and other anti-infective therapies.

Read more ...